Protocol
EA2174
Sponsor
ECOG-A
Title
A Phase II/III Study of Peri-operative Nivolumab and Ipilimumab in Patients with Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma
For More Information:
Click Here
Protocol
EA2174
Sponsor
ECOG-A
Title
A Phase II/III Study of Peri-operative Nivolumab and Ipilimumab in Patients with Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma
For More Information:
Click Here